Emily McGinnis

Led patient advocacy and government affairs at AveXis; instrumental in the launch of Zolgensma, where she played a key role in collaborating with advocacy on newborn screening development and implementation efforts to rapidly diagnose spinal muscular atrophy patients in need of treatment.